Literature DB >> 7956324

Hepatitis C virus: structure, protein products and processing of the polyprotein precursor.

M Houghton1, M Selby, A Weiner, Q L Choo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956324     DOI: 10.1159/000423264

Source DB:  PubMed          Journal:  Curr Stud Hematol Blood Transfus        ISSN: 0258-0330


× No keyword cloud information.
  5 in total

1.  A potential RNA drug target in the hepatitis C virus internal ribosomal entry site.

Authors:  R Klinck; E Westhof; S Walker; M Afshar; A Collier; F Aboul-Ela
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

2.  Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.

Authors:  Irina Sominskaya; Dace Skrastina; Andris Dislers; Denis Vasiljev; Marija Mihailova; Velta Ose; Dzidra Dreilina; Paul Pumpens
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

Review 4.  Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era.

Authors:  Saliha D Durmuş Tekir; Kutlu Ö Ülgen
Journal:  Biotechnol J       Date:  2012-11-29       Impact factor: 4.677

5.  Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5'UTR sequence.

Authors:  S Tang; A J Collier; R M Elliott
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.